3 research outputs found

    Criterios de implementación ISO 14000:2015, Caso de Estudio Empresa Ecocapital E.S.P

    Get PDF
    Tabla No 1. Maquinaria utilizada/ Tabla No 2. Criterios de Evaluación del mantenimiento de equipos/ Tabla No 3. Materias primas utilizadas en los sistemas de tratamiento/ imagen diagrama de flujo con etapas del proceso/ imagen de matriz de impactos ambientales/ Figura No 1 Resumen normatividad residuos peligrosos e imagen del ciclo PHVAAl realizar la auditoría interna se puede apreciar que Ecocapital cuenta con personal especializado en el Manejo Integral de Residuos Sólidos Peligrosos (Respel), para la efectividad de los procesos han implementado el uso de equipos y maquinaria con alta tecnología al igual que la flota vehicular que es monitoreada constantemente. En cuanto al sistema de tratamiento de Respel, la entidad ha diseñado un Plan de Manejo Ambiental resaltando la responsabilidad ambiental, obteniendo certificación ISO 14001de 2004, la cual debe ser actualizada por ISO 14001 de 2015, la cual ayudará a la mejora de hallazgos que se pudieron apreciar al momento de auditar cada proceso en sus diferentes áreas; como el permiso de vertimientos, sistema de tratamiento de aguas residuales, disposición final de Respel y emisiones atmosféricas producto del proceso de esterilización en las autoclaves. Pese a las certificaciones obtenidas (normas de Gestión de Calidad NTC GP 1000:2009 e ISO 9001:2008, Gestión Ambiental ISO 14001:2004 y Sistema de Gestión en Seguridad y Salud Ocupacional OHSAS 18001:2007), se puede analizar que hay falencias que ponen en riesgo a la organización por las afectaciones ambientales, por lo que se hace urgente y oportuno la comunicación con la alta dirección y poner en evidencia los hallazgos detectados, para que a su vez se tomen la medidas correctivas evitando a futuro sanciones por parte de las autoridades ambientales que perjudicaran a Ecocapital y todo su equipo de colaboradores y contratistas, teniendo en cuenta la gran labor que desarrolla la organización al medio ambiente y a la comunidad en general.When carrying out the internal audit, it can be seen that Ecocapital has personnel specialized in the Comprehensive Management of Dangerous Solid Waste (Respel), for the effectiveness of the processes they have implemented the use of equipment and machinery with high technology, as well as the vehicle fleet that it is constantly monitored. Regarding the Respel treatment system, the entity has designed an Environmental Management Plan highlighting environmental responsibility, obtaining ISO 14001 certification from 2004, which must be updated by ISO 14001 from 2015, which will help to improve the findings that are They were able to appreciate when auditing each process in its different areas; such as the dumping permit, wastewater treatment system, final disposal of Respel and atmospheric emissions resulting from the sterilization process in autoclaves. Despite the certifications obtained (NTC GP 1000: 2009 and ISO 9001: 2008 Quality Management standards, ISO 14001: 2004 Environmental Management and OHSAS 18001: 2007 Occupational Health and Safety Management System), it can be analyzed that there are shortcomings that they put the organization at risk due to environmental damage, which is why communication with senior management is urgent and timely and the detected findings are highlighted, so that in turn corrective measures are taken, avoiding future sanctions by the environmental authorities that harm Ecocapital and its entire team of collaborators and contractors, taking into account the great work carried out by the organization for the environment and the community in general

    International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

    No full text
    We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN
    corecore